Inclusion Criteria:  Adult 18 years of age or older; and Self-identify as Black/African American  Presenting with high-risk EC established by anatomic pathology as tumor stage and grade classification by the following:  Pathology documentation from any hospital/clinic/medical center, and FIGO Stage 1A with Grade 2, Grade 3, or Grade 4 of any histology type or FIGO Stage 1A with non-endometrioid (carcinosarcoma, serous, clear cell, undifferentiated or mixed) histology FIGO Stage 1B, 2, 3, or 4 of any grade or histology Recurrent endometrial cancer of any stage or grade Documented provider recommendation and patient plan to initiate adjuvant therapy with chemotherapy, radiation, and/or immunotherapy.  Exclusion Criteria:  Participants must not have any of the following exclusion criteria:  Newly diagnosis of FIGO Stage IA Grade 1 endometroid adenocarcinoma Previous history of other cancer diagnosis requiring chemotherapy, radiation therapy, or immunotherapy within the past 12 months; Incarcerated in a detention facility or in police custody (patients wearing a monitoring device can be enrolled) at baseline/screening; Contraindication to all non-surgical therapy available for endometrial cancer (i.e., chemotherapy, radiation, and immunotherapy contraindicated); Enrollment into hospice prior to randomization Unable to provide written informed consent in English; Unable to be contacted for research surveys; Recent hospitalization for psychiatric illness in the past 6 months